Increased serum phosphate is known to affect bone metabolism directly and indirectly through the development of adaptive hormonal mechanisms aimed at preventing hyperphosphatemia, such as the increase in PTH and FGF23 and the reduction in calcitriol [37]. The gene discussed is PTH; the disease is hyperphosphatemia.